These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35398452)

  • 1. Multiparametric assessment of sensorimotor abnormalities in vulnerable populations: A window of opportunity.
    Hirjak D; Meyer-Lindenberg A; Sambataro F; Wolf RC
    Neurosci Biobehav Rev; 2022 Jun; 137():104658. PubMed ID: 35398452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review.
    Wilson RP; Bhattacharyya S
    J Psychopharmacol; 2016 Feb; 30(2):99-111. PubMed ID: 26510450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population.
    Cadenhead KS
    Psychiatry Res; 2011 Jul; 188(2):208-16. PubMed ID: 21555157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
    Reid S; Bhattacharyya S
    Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study.
    Griffith-Lendering MF; Wigman JT; Prince van Leeuwen A; Huijbregts SC; Huizink AC; Ormel J; Verhulst FC; van Os J; Swaab H; Vollebergh WA
    Addiction; 2013 Apr; 108(4):733-40. PubMed ID: 23216690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
    Hides L; Dawe S; Kavanagh DJ; Young RM
    Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study.
    Gerlach J; Koret B; Gereš N; Matić K; Prskalo-Čule D; Zadravec Vrbanc T; Lovretić V; Skopljak K; Matoš T; Šimunović Filipčić I; Filipčić I
    Psychiatr Danub; 2019 Jun; 31(Suppl 2):162-170. PubMed ID: 31158117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.
    Zhang X; de Leon J; Crespo-Facorro B; Diaz FJ
    J Biopharm Stat; 2020 Sep; 30(5):916-940. PubMed ID: 32511941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.
    Alcover KC; Oluwoye O; Kriegel L; McPherson S; McDonell MG
    Schizophr Res; 2019 Sep; 211():86-87. PubMed ID: 31378555
    [No Abstract]   [Full Text] [Related]  

  • 10. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Psychiatry Res; 2017 Sep; 255():36-41. PubMed ID: 28521146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency.
    Potvin S; Stip E; Roy JY
    Can J Psychiatry; 2004 Oct; 49(10):711. PubMed ID: 15560324
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
    Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
    Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and psychosis.
    Degenhardt L; Hall W
    Curr Psychiatry Rep; 2002 Jun; 4(3):191-6. PubMed ID: 12003681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care.
    Isaac M; Isaac M; Holloway F
    Hum Psychopharmacol; 2005 Apr; 20(3):207-10. PubMed ID: 15682431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.
    Hahn B
    Schizophr Bull; 2018 Jan; 44(1):46-53. PubMed ID: 29083450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways to psychosis in cannabis abuse.
    Shrivastava A; Johnston M; Terpstra K; Bureau Y
    Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):30-5. PubMed ID: 23491968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study.
    Delvecchio G; Oldani L; Mandolini GM; Pigoni A; Ciappolino V; Schiena G; Lazzaretti M; Caletti E; Barbieri V; Cinnante C; Triulzi F; Brambilla P
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32894263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.